The Top 25 Healthcare Technology Leaders of Austin for 2023

The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Austin for 2023. Undoubtedly, Austin stands as a bastion of health and well-being. Its extensive network of hiking, biking, and running trails, complemented by a state-of-the-art velodrome catering to cycling enthusiasts, reflects the city's unwavering dedication to its residents' physical fitness.

This steadfast commitment extends to a wealth of outstanding healthcare resources within Austin. Notably, four area hospitals have recently been named to a list of the top 100 hospitals in the U.S. Furthermore, Austin serves as a hub for cutting-edge healthcare technology companies on a global scale. The leaders in these companies, featured in this year's list, have consistently exhibited exceptional leadership acumen. They adeptly strike a balance between achieving remarkable business success and maintaining a profound commitment to enhancing patient outcomes.

Some of the distinguished honorees on this year’s list include Mike Carruthers, who brings more than 20 years of experience serving as CFO for publicly-traded biopharmaceutical companies to his current role as CFO at Edgewise Therapeutics. Another prime example is Greg Sansom, who started as an auditor with Arthur Andersen and now serves as the CFO for OriGen Biomedical. Additionally, this year we are honoring Jacylyn Dougherty, Elligo Health Research's Chief Information and Technology Officer, who has more than two decades of progressive technology and data experience within the life sciences industry.

Please join us in celebrating The Top 25 Healthcare Technology Leaders of Austin for 2023.


1. Fred Turner
Company: Curative
Title: Chief Executive Officer

Fred Turner is the CEO of Curative, a leading health care services company with an AM-Best rating of A- that has created and launched a first-of-its-kind employer-based health insurance plan. Launched in 2020, Curative is reengineering health insurance by providing unmatched simplicity and cost transparency with a competitive monthly premium and zero out-of-pocket costs.

Turner, a British scientist, is from West Yorkshire. Previously, he was a CEO at Shield Bio. Before that, he was a CEO at TL Biolabs Corp. Turner earned a master’s in biochemistry and molecular biology from the University of Oxford.


2. Jeffrey Binder
Company: Exactech
Title: Chairman and CEO

As CEO of Exactech, Jeffrey Binder is a 30-year veteran of the medical device and diagnostic industry. His company is a global medical device company that develops and markets orthopedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific.

Previously, Binder served as CEO and President of Biomet Inc. from February 2007 until June 2015. His other previous positions include a stint as Senior Vice President of Diagnostic Operations of Abbott Laboratories from January 2006 through February 2007. Prior to that, he served as President of Abbott Spine from June 2003 until January 2006; and was President and CEO of Spinal Concepts from 2000 until Spinal Concepts was acquired by Abbott Laboratories in June 2003. Binder holds a bachelor’s in applied mathematics from Yale University and a master’s in public affairs from the Princeton School of Public and International Affairs.


3. Taylor Schreiber
Company: Shattuck Labs
Title: Chief Executive Officer

Taylor Schreiber is a co-founder of Shattuck Labs and currently serves as CEO and a member of the Board of Directors. Before his appointment as CEO in January 2020, Schreiber served as the company’s Chief Scientific Officer. Schreiber is the lead inventor of Shattuck’s ARC technology platform. Shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Prior to Shattuck, Schreiber served as Chief Scientific Officer of Heat Biologics, Inc., where he was a co-inventor of significant elements of Heat’s ImPACT and ComPACT technology platforms.

Schreiber was also the co-inventor of Pelican Therapeutics ‘s TNFRSF25 agonist technology, where he served as Chairman of the Scientific Advisory Board. Schreiber has numerous publications in the field of tumor immunology and immunotherapy, spanning the subjects of cancer vaccines, therapeutic proteins and antibodies, adenosinergic and IDO mediated immunosuppression and regulatory T cell biology. Schreiber received both his M.D. and Ph.D. degrees from the Sheila and David Fuente Program in Cancer Biology at the University of Miami Miller School of Medicine. He also received his B.A. in Biology from Bucknell University.


4. Jacylyn Dougherty
Company: Elligo Health Research
Title: Chief Information & Technology Officer

Jacylyn Dougherty has more than 20 years of progressive technology and data experience within the life sciences industry. As Elligo’s Chief Information and Technology Officer, she is responsible for technology strategy and execution that aligns with Elligo’s business model. Dougherty also oversees the product and engineering teams that have developed Elligo’s proprietary platform, IntElligo® Research Stack. Elligo Health Research accelerates clinical trials through EHR data, their proprietary IntElligo® technology, and direct access to known, diverse patients from more than 115 hospitals and major health systems, 200 healthcare-based sites, and 100 research-based sites.

Before joining Elligo, Dougherty was the Chief Information Officer at Theorem Clinical Research (now Chiltern International). While there, she was a key part of an executive team that spun the company out of a Fortune 500 parent and achieved unprecedented valuation growth within four years of private equity ownership. Dougherty led her team and the business to revolutionize over 70 percent of the applications portfolio, enabling new business services, such as clinical trial data analytics services. She began her career at SmithKline Beecham (now GlaxoSmithKline), moving to Omnicare Clinical Research, ultimately becoming Chief Information Officer. Dougherty is PMP certified, has her bachelor’s in management information systems and marketing from LaSalle University and an MBA from Villanova University.


5. Joe Ellison
Company: Maxor National Pharmacy Services
Title: Chief Human Resources Officer

Joe Ellison is the Chief Human Resources Officer of Maxor National Pharmacy Services. Established in 1926, Maxor is a leading pharmacy services platform that consists of the following business segments: MaxorPlus, Maxor Pharmacy Management and Consulting Services, Maxor Specialty, and PickPoint.

Ellison brings over 20 years of leadership experience in complex, multi-site healthcare and technology businesses. Prior to joining Maxor, Ellison led nationwide HR teams in PBM, specialty pharmacy, and disease care management. Ellison graduated from Amberton University with an MBA in management and from the University of North Texas with an undergraduate degree in business administration.


6. Richard Rew
Company: Tabula Rasa HealthCare
Title: Chief Legal Officer

Richard Rew is the Chief Legal Officer and Corporate Secretary of Tabula Rasa Healthcare. Tabula Rasa HealthCare provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combating medication overload and reducing adverse drug events.

Rew oversees all legal matters for the company, including regulatory compliance, litigation, corporate governance, and corporate development. With nearly 30 years’ experience in corporate law, supporting public companies, primarily in the healthcare technology space, he brings a wealth of legal, corporate development and public company compliance expertise to TRHC.

Previously, Rew was Senior Vice President, General Counsel & Secretary at IsoPlexis Corporation and served in SVP & General Counsel roles at public medical device companies, ArthroCare Corporation and Luminex Corporation where he was instrumental in implementing corporate governance policies, compliance programs, and in maximizing the value of corporate development. He earned a JD from the University of Oklahoma College of Law and an undergraduate degree from The University of Texas at Austin.

Richard Rew Insight

"I am grateful to be named among the top healthcare leaders in Austin. This recognition serves to highlight Tabula Rasa Healthcare’s crucial work helping to improve the health and well-being of people with some of the most complex healthcare needs."


7. Joe Segars
Company: International Biomedical
Title: CEO

Joe Segars is the CEO of International Biomedical, an Austin, Texas-based company that designs, manufactures, and distributes innovative neonatal and perinatal products and technologies to hospitals worldwide. For over 45 years, their mission has been to provide the best possible outcomes for the newborn infant, the critically ill, and their families. Their family owned and operated company stands 100+ strong, spans the globe, and promotes a culture of respect and integrity.

While manufacturing quality products is their top priority, International Biomedica is also committed to giving back to their local communities and reducing their impact on the environment. Segars graduated from Tulane University School of Medicine with an MD and from Texas Wesleyan University with an undergraduate degree.


8. Paul Lammers
Company: Triumvira Immunologics
Title: Chief Executive Officer

Paul Lammers, MD, MSc, joined Triumvira Immunologics as President and CEO in January 2018. Triumvira Immunologics, Inc. is a clinical-stage company developing unique, non-gene edited, first-in-class targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors. The company's proprietary T cell Antigen Coupler (TAC) technology is a robust and versatile platform that activates natural T cell functions differently from cell therapies such as CAR-T and engineered T cell receptor (TCR) therapies. Triumvira is headquartered in Austin, Texas, with research facilities in Hamilton, Ontario, and South San Francisco, California.

Before Triumvira, Lammers served as President & CEO at Mirna Therapeutics, where he helped raise $160 million. Previously, he served as Chief Medical Officer and Head of US Product Development for EMD Serono. During his early industry tenure, Lammers also held various executive/senior management positions in clinical development, medical and regulatory affairs, at different pharmaceutical companies. He also worked at small public and privately held biotech companies. Additionally, Lammers serves as Lead Independent Director for publicly-traded Salarius Pharmaceuticals, and as Director for a private biotech company, Immunomet. Lammers graduated from Radboud University with an MD and an undergraduate degree in reproductive biology.

Paul Lammers Insight

“Creating the cell therapy medicines for patients with gastric cancers”


9. Rob Moore
Company: Stryker
Title: Vice President of Sales

Rob Moore is the Vice President of Sales of Stryker. He first joined the company in 2016 as director of sales in Upper Extremities. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes.

Previously, Moore was an executive director of global sales at Greatbatch Medical. Before that, he served as a district manager at Smith & Nephew. Earlier in his career, he worked with Boston Scientific as a business development manager. Moore earned an undergraduate degree in business administration from Truman State University.


10. Chuck Schneider
Company: Boston Scientific
Title: Vice President of Healthcare Economics & Market Access

Chuck Schneider is the Vice President of Healthcare Economics and Market Access of Boston Scientific. As a global medical technology leader for more than 40 years, Boston Scientific advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. Notably, Schneider is a global leader in medical device, diagnostics and biopharma market access, policy and healthcare economics.
He has more than 26 years of diverse healthcare leadership experience, including senior level management of health insurance and managed care organizations, health care provider operations and medical technology reimbursement.

During his career, Schneider has established landmark programs in clinical trial reimbursement management, health economic outcomes, patient access – as well as innovative solutions that directly resulted in favorable coverage for established and emerging technologies. Before joining Boston Scientific, Schneider was a head of global market access and reimbursement at Roche Sequencing USA. Before that, he served as global VP of healthcare economics, reimbursement and guidelines at St. Jude Medical. Earlier in his career, he worked with Prudential Insurance, PruCare of California, and Florida as a director. Schneider graduated from the University of Southern California with an undergraduate degree in political science.


11. Mark Jesser
Company: Integra Life Sciences
Title: Chief Digital Officer

At Integra Life Sciences, Mark Jesser is the VP and Chief Digital Officer, responsible for helping define the company’s digital roadmap and support the execution of its digital plans. Integra LifeSciences, a world leader in medical technology with headquarters in Princeton, New Jersey, was founded in 1989 with the acquisition of an engineered collagen technology platform used to repair and regenerate tissue. Since then, Integra has expanded its base regenerative technology product portfolio to include surgical instruments, neurosurgical products and advanced wound care products, through global acquisitions and development of new and innovative products and technologies to address unmet patient needs and improve outcomes.

Jesser has 15 years of successfully developing and launching digital platforms and strategies that create transformational solutions for healthcare customers and patients. Prior to joining Integra in August 2022, he was the VP of strategic innovation and digital solutions at Becton Dickinson, where he led innovation and digital product management for the Medication Delivery Solutions division. Prior to this role, he spent 10 years at Abbott Diabetes Care. He started his career in management consultancy and worked in marketing and product management. Jesser received his bachelor's from the University of Massachusetts at Amherst. He has a master’s in international business from the Catholic University in Chile and an MBA from the University of Texas at Austin.


12. Matt Chavez
Company: Komodo Health
Title: Vice President, Life Sciences

Matt Chavez is the Vice President of Life Sciences at Komodo Health. He joined the company in 2021 as an Area Vice President of Life Sciences Intermediaries. Komodo Health is a technology company that believes smarter, more innovative use of data and analytics is essential for reducing the burden of disease. They apply advanced data science techniques to our first-of-its-kind Healthcare Map™, which leverages the patient journeys of more than 325 million de-identified individuals.

Chavez started his career 11 years ago as an Administrative Residency in Quality Management and Service Excellence at HCA Healthcare, where he performed clinical outcomes analysis, performance improvement, and service excellence initiatives. From there he went on to Altus Health, before eventually rising to McKesson, where he managed executive-level partnerships with oncology and rare disease-focused life science companies for McKesson's technology and insights business, Ontada. Chavez earned his MS in Technology Commercialization from Texas McCombs School of Business and his MBA in Healthcare & Strategy from Lamar University. Chaves graduated from Texas State University with an undergraduate degree in healthcare administration.


13. Matt Wallace
Company: Insighttech
Title: Vice President of Sales

Matt Wallace is the Vice President of Sales at Insighttech, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy. The company's Exablate Neuro platform focuses on sound waves, safely guided by MRI, to provide tremor treatment to patients with medication-refractory Essential Tremor and Parkinson's Disease.

Before joining Insighttech, Wallace was a Director of Sales at Auris Health. He also served as an Area Vice President at iRhythm Technologies, Inc. Earlier in his career, he was an Area Sales Manager at Intuitive Surgical. Wallace graduated from the University of Central Florida with an undergraduate degree in biology.


14. Ivor Clarke
Company: SubjectWell
Title: Chief Innovation Officer

Ivor Clarke is the Chief Innovation Officer of SubjectWell. Founded in 2012, SubjectWell supports clinical trials for 15 of the top 20 pharmaceutical companies, reaching patients across four continents. With over 230 employees and growing — located in Austin, TX and Cape Town, South Africa —SubjectWell helps pharmaceutical and biotech companies find qualified patients in over 175 therapeutic areas.

Clarke has 24 years of experience. He began his career in 1999. Before joining SubjectWell, Clarke was a principal at Hoot Call. Before that, he served as a VP at Datran Media. Earlier in his career, he worked with Microsoft as a program manager. Clarke graduated from Carnegie Mellon University with an undergraduate degree in human-computer interaction, information and decision systems.


15. Kara Connell
Company: NeuFit
Title: Vice President of Sales and Customer Experience

Kara Connell is the Vice President of Sales and Customer Experience at NeuFit. NeuFit is a medical device company that is shifting the paradigm of rehabilitation and recovery by focusing on the nervous system. Using specialized direct current technology, the company’s NEUBIE device helps patients restore function lost due to neurological injuries or conditions, recover faster from pain, injury, and surgery, and optimize performance. Connell has helped lead the company’s growth from only a few employees to one of the fastest-growing companies in the U.S., recognized by the INC-5000 as one of the fastest-growing private healthcare companies for the past two years.

Connell began her career in advertising sales with new business and enterprise-level accounts. Prior to joining the NeuFit team, she served in the operating room as a representative for Integra LifeSciences in orthopedics and biologics. She holds an undergraduate degree in biology from the University of Texas at Austin.


16. Charles York
Company: Day One Biopharmaceuticals
Title: Chief Operating and Financial Officer

Charles York joined Day One Biopharmaceuticals from Aeglea BioTherapeutics, where he served as Chief Operating and Financial Officer. At Aeglea BioTherapeutics, he was also a member of the leadership team. Prior to joining Aeglea, York served as consulting chief financial officer at Bridgepoint Consulting, focusing on growth stage life science companies. He earned his bachelor’s in business administration and accounting from University of Connecticut and his MBA from the McCombs School of Business at The University of Texas at Austin.

York brings more than 20 years of strategic capital formation and leadership experience to his role as Chief Operating and Financial Officer at Day One, a clinical-stage biopharmaceutical company that was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. The company’s name was inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan.


17. Sushma Shivaswamy
Company: XBiotech USA
Title: Chief Scientific Officer

Sushma Shivaswamy was appointed XBiotech USA’s Chief Scientific Officer in November 2017. As CSO, Shivaswamy oversees all scientific and technical operations with respect to research and development and GMP production of antibody. Notably, XBiotech is a fully integrated global biosciences company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Shivaswamy previously served as the company’s Vice President of Research and Development since January 2015, where she led teams involved in various Research & Development projects.

Shivaswamy has been with tXBiotech since 2009, having held positions of Director of Research & Development (2011-2015) and Senior Scientist (2009-2011). Prior to joining XBiotech, she was a postdoctoral researcher at the Center for Systems and Synthetic Biology at the University of Texas at Austin. She has a Ph.D. degree in Molecular Biology from the Center for Cellular and Molecular Biology, India. Shivaswamy’s academic studies have involved elucidating mechanisms for regulation of gene expression.


18. Matt Osburn
Company: Caligor Coghlan Pharma Services
Title: Chief Financial Officer

Matt Osburn began his professional career 22 years ago. Today, he is the Chief Financial Officer at Caligor Coghlan Pharma Services, an experienced, responsive, and trusted clinical supply services partner helping small- and medium-sized innovators and CROs expedite the clinical supply chain, improving the quality of life for patients in need. For more than 27 years, they’ve dedicated themselves to supporting innovators’ clinical trial supply chain needs, including clinical packaging and labeling services, kit and label design services, global warehousing and distribution, and comparator and commercial drug sourcing. Osburn is responsible for overseeing and managing CalCog’s financial & IT functions and developing and maintaining CalCog’s annual operating plan and budget.

Osburn’s extensive experience in corporate financial management and leadership allows CalCog, its partners, and suppliers to thrive within a responsibly and effectively managed organization. Osburn got his start in 2001 as a controller at Schlotzsky's, Inc. From there, he went on to Entorian Technologies, before eventually rising to VP of finance and corporate controller at Caligor Coghlan Pharma Services, his most recent position prior to joining CalCog. Osburn graduated with an MPA from the McCombs School of Business at The University of Texas at Austin. He also graduated from Nebraska Wesleyan University with an undergraduate degree in economics.


19. Ryan Klebba
Company: STERIS
Title: Vice President of Business Development

Ryan Klebba is the Vice President of Business Development at STERIS. He first joined the company in 2020. STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. Founded as Innovative Medical Technologies in Ohio in 1985, the company was renamed STERIS in 1987.

However, some of the businesses that have been acquired and integrated into STERIS (such as American Sterilizer Company) have much longer operating histories. STERIS has approximately 16,000 Associates worldwide; and operates in more than 100 countries. Previously, Klebba was a VP of business development and b2b sales at IMS. He earned a degree in speech in communication and business from Texas A&M University.


20. Joel Kocher
Company: HumanN
Title: Co-Founder and CEO

Joel Kocher is the Co-Founder and CEO of HumanN, a company focused on superior functional nutrition products for the health & fitness industry with science-backed products that support heart, brain, endurance, energy and other benefits essential to promoting a healthy lifestyle. Kocher has 20 years of senior leadership experience in the technology industry in companies ranging from $100 million in revenues to multi-billion. He was once described by BusinessWeek Magazine as a ”a marketing whiz who's needle is stuck on motivate."

Kocher is recognized for presiding over Dell's explosive growth in the early to mid 1990's as its number 2 executive behind founder Michael Dell during the company’s meteoric rise to the Fortune 500. Advertising industry icon Fred Goldberg stated in his book that “next to Michael Dell, Joel’s leadership was responsible more than anyone else’s for Dell’s growth in those early years. Joel was an important part of the brand itself.” After he left Dell, Kocher held a broad set of leadership positions in both private and public companies. He graduated from the University of Florida with an undergraduate degree in marketing.


21. Tadd Lazarus
Company: Achieve Health Management
Title: Chief Medical Officer

Tadd Lazarus is the Chief Medical Officer at Achieve Health Management, a company that provides patient monitoring and case management services to Skilled Nursing Facilities, Hospital Systems, Physician Groups, and Health Plans. AHM offers providers with affordable options by leveraging a highly skilled, multilingual and credentialed community-based workforce comprised of telehealth physicians, nurses, health coaches and case managers. Lazarus is an experienced Chief Medical Officer with a demonstrated history of working in the Biotechnology and IVD Industries.

He has expertise in a wide range of areas, including Medical Diagnostics, Molecular Biology, Market Research, and Companion Diagnostics Development and Submission, among others.
Notably, Lazarus got his start in 1988 as an attending physician at St. Vincent’s Hospital and Medical Center of New York. From there, he went on to St. Clare’s Hospital and Health Center, before eventually rising to chief medical officer at Inivata, Inc., his most recent position prior to joining Achieve Health Management. Lazarus graduated from Ross University School of Medicine with an MD and from Marlboro College with an undergraduate degree in biology.


22. Michael Morigi
Company: Thomas Scientific
Title: Vice President of Sales

Michael Morigi is the Vice President of Sales at Thomas Scientific. He first joined the company in 2020 as sales director. For 120+ years, Thomas Scientific has provided the latest in equipment and supplies to the science community. In accordance with the tradition of the original founders, Thomas Scientific provides individualized customer service, innovative scientific equipment, and a comprehensive portfolio offering a wide selection of product listings at a great deal. More than just a distributor, they offer an array of service solutions, including Thomas Inventory Management Solutions (custom VMI solutions), equipment financing, and more.

Previously, Morigi was a president at Double M Advisors LLC. Before that, he served as a VP of sales at Durisan. Earlier in his career, he worked with Baxter International Inc. as a sales representative. Morigi earned an undergraduate degree in marketing from The University of Texas at Arlington’s College of Business.


23. Scott Barrett
Company: Benchmark Research
Title: Co-founder, President and Chief Operating Officer

Scott Barrett is the Co-foudner, President and Chief Operating Officer of Benchmark Research, which was launched 1997. Since then, they have developed a track record of safety and expertise, having conducted more than 1,000 trials with 40,000+ participants. They work in partnership with the private and public sectors at clinics located in California, Louisiana and Texas to ensure you get safe and effective medications and vaccines.

Barrett has 34 years of experience. He began his career in 1989. Before launching Benchmark Research, Barrett was a project manager at SCIREX Corporation. Before that, he served as a project manager at PPD. Earlier in his career, he worked with Pharmaco (PPD) as a clinical research associate. Barrett graduated from The University of Texas at Austin with an undergraduate degree in communications.


24. Greg Sansom
Company: OriGen Biomedical
Title: Chief Financial Officer

Greg Sansom is the Chief Financial Officer at OriGen Biomedical, a leading producer of cryopreservation, cell culture, and intensive respiratory care products. OriGen’s focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. Sansom joined OriGen Biomedical in June of 2009. Today, he is responsible for all aspects of the company’s finance and accounting functions. He also manages payroll and benefits administration. Sansom has twenty-three years of financial management and accounting experience in a variety of strategic and financial executive roles.

Before joining OriGen Biomedical, Sansom served as the CFO for Interstate Connections, Inc. where he managed the finance and accounting, human resources, and recruiting functions for a $30 million privately held chain of wireless retail stores. Prior to joining Interstate Connections, Sansom was involved with a number of organizations including Ambion, Barrett Kendall Publishing, Crossroads Systems, Dell Computers, Digital Lifestyles Group, and Harcourt Brace & Company. He began his career as an Auditor with Arthur Andersen. Sansom graduated magna cum Laude from Harding University with a bachelor's in business administration in accounting. He also obtained his MS in accounting from Harding University and is a CPA.


25. Mike Carruthers
Company: Edgewise Therapeutics
Title: Chief Financial Officer

Mike Carruthers is the Chief Financial Officer at Edgewise Therapeutics. He first joined the company in 2020. Edgewise Therapeutics, Inc., is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative treatments for severe, genetic neuromuscular and cardiac disorders for which there is significant unmet medical need. Carruthers boasts more than 20 years of experience serving as CFO for publicly-traded biopharmaceutical companies. In particular, he has extensive experience across corporate finance and strategic planning including IPOs, secondary offerings and M&A transactions.

Previously, Carruthers served as Interim President of Nivalis Therapeutics, a publicly traded company acquired by Alpine Immune Sciences, in 2017. He also served as the company’s CFO and Secretary from 2015 to 2017. From 1998 to 2015, he served as CFO for Array BioPharma Inc., a publicly traded company acquired by Pfizer Inc. Prior to this, he served as CFO of Sievers Instruments; Treasurer and Controller for the Waukesha division of Dover Corporation; and accountant with Coopers & Lybrand. Away from Edgewise, Carruthers serves on the boards of Elevation Oncology (Nasdaq: ELEV) and OnKure, Inc., a privately-held biopharmaceutical company. He received a BS in accounting from the University of Colorado and an MBA. from the University of Chicago.